1	LONDON	london	NNP	_	5	nn	_
2	May	may	NNP	_	5	npadvmod	_
3	19	0	CD	_	2	num	_
4	(	(	-LRB-	_	5	punct	_
5	Reuters	reuters	NNP	_	25	nsubj	25:A0
6	)	)	-RRB-	_	5	punct	_
7	-	-	:	p2=.	5	punct	_
8	Britain	britain	NNP	_	12	poss	_
9	's	's	POS	_	8	possessive	_
10	Jupiter	jupiter	NNP	_	11	nn	_
11	Fund	fund	NNP	_	12	nn	_
12	Management	management	NNP	_	5	appos	_
13	,	,	,	_	5	punct	_
14	a	a	DT	_	18	det	_
15	top	top	JJ	p2=RB	17	hmod	_
16	-	-	HYPH	_	17	hyph	_
17	30	0	CD	p2=NN	18	nn	_
18	shareholder	shareholder	NN	_	5	appos	_
19	in	in	IN	_	18	prep	_
20	UK	uk	NNP	_	21	nn	_
21	pharmaceuticals	pharmaceutical	NNS	p2=VBZ	19	pobj	_
22	giant	giant	JJ	p2=NN	23	amod	_
23	AstraZeneca	astrazeneca	NNP	_	18	appos	_
24	,	,	,	_	5	punct	_
25	said	say	VBD	pb=say.01	0	root	_
26	it	it	PRP	_	28	nsubjpass	28:A1=PPT
27	is	be	VBZ	_	28	auxpass	_
28	disappointed	disappoint	VBN	p2=JJ|pb=disappoint.01	25	ccomp	25:A1=PPT
29	with	with	IN	_	28	prep	28:A0=PAG
30	the	the	DT	_	31	det	_
31	firm	firm	NN	_	33	poss	_
32	's	's	POS	_	31	possessive	_
33	rejection	rejection	NN	_	29	pobj	_
34	of	of	IN	_	33	prep	_
35	U.S.	u.s.	NNP	_	37	nn	_
36	rival	rival	JJ	p2=NN	37	amod	_
37	Pfizer	pfizer	NNP	p2=NN	41	poss	_
38	's	's	POS	_	37	possessive	_
39	final	final	JJ	_	41	amod	_
40	takeover	takeover	NN	_	41	nn	_
41	offer	offer	NN	p2=VBP	34	pobj	_
42	.	.	.	_	25	punct	_

1	"	"	``	_	10	punct	_
2	We	we	PRP	_	3	nsubj	3:A1=PPT;4:A1=PPT
3	are	be	VBP	pb=be.01	0	root	_
4	disappointed	disappoint	VBN	p2=VBG|pb=disappoint.01	3	acomp	3:A2=PRD
5	the	the	DT	_	6	det	_
6	board	board	NN	_	10	nsubj	10:A0=PAG
7	of	of	IN	_	6	prep	_
8	AstraZeneca	astrazeneca	NNP	_	7	pobj	_
9	has	have	VBZ	_	10	aux	_
10	rejected	reject	VBN	pb=reject.01	4	ccomp	4:A0=PAG
11	Pfizer	pfizer	NNP	p2=NN	14	poss	_
12	's	's	POS	_	11	possessive	_
13	latest	late	JJS	_	14	amod	_
14	offer	offer	NN	p2=VBP	10	dobj	10:A1=PPT
15	so	so	RB	_	16	advmod	_
16	categorically	categorically	RB	_	10	advmod	10:AM-TMP
17	.	.	.	_	3	punct	_

1	They	they	PRP	_	3	nsubj	3:A0=PAG;6:A0=PAG
2	should	should	MD	_	3	aux	3:AM-MOD
3	have	have	VB	pb=have.03	0	root	_
4	at	at	RB	p2=IN	5	advmod	_
5	least	least	RBS	_	6	advmod	6:AM-ADV
6	engaged	engage	VBN	p2=JJ|pb=engage.01	3	xcomp	_
7	in	in	IN	_	6	prep	6:A2=PPT
8	a	a	DT	_	10	det	_
9	constructive	constructive	JJ	_	10	amod	_
10	conversation	conversation	NN	_	7	pobj	_
11	with	with	IN	_	10	prep	_
12	Pfizer	pfizer	NNP	_	11	pobj	_
13	on	on	IN	_	10	prep	_
14	the	the	DT	_	15	det	_
15	details	detail	NNS	_	13	pobj	_
16	of	of	IN	_	15	prep	_
17	the	the	DT	_	18	det	_
18	offer	offer	NN	_	16	pobj	_
19	to	to	TO	_	20	aux	_
20	assess	assess	VB	pb=assess.01	18	infmod	_
21	the	the	DT	_	22	det	_
22	opportunities	opportunity	NNS	_	20	dobj	20:A1=PPT;28:A1=PPT
23	that	that	WDT	p2=IN	28	dobj	28:R-A1
24	a	a	DT	_	26	det	_
25	combined	combine	VBN	p2=JJ|pb=combine.01	26	amod	_
26	entity	entity	NN	_	28	nsubj	28:A0=PAG;25:A3=PRD
27	could	could	MD	_	28	aux	28:AM-MOD
28	bring	bring	VB	pb=bring.01	22	rcmod	_
29	.	.	.	_	3	punct	_
30	"	"	''	_	3	punct	_

1	said	say	VBD	pb=say.01	0	root	_
2	Jupiter	jupiter	NNP	_	4	nn	_
3	fund	fund	NN	_	4	nn	_
4	manager	manager	NN	_	6	nn	_
5	Alastair	alastair	NNP	_	6	nn	_
6	Gunn	gunn	NNP	_	1	nsubj	1:A0
7	.	.	.	_	1	punct	_

1	"	"	``	_	4	punct	_
2	There	there	EX	p2=RB	4	expl	_
3	now	now	RB	_	4	advmod	4:AM-TMP
4	seems	seem	VBZ	pb=seem.01	0	root	_
5	little	little	JJ	_	6	amod	_
6	room	room	NN	_	7	nsubj	7:A0=PAG
7	left	leave	VBD	p2=VBN|pb=leave.02	4	ccomp	4:A1=PPT
8	to	to	IN	p2=TO	7	prep	7:A2=GOL
9	manoeuvre	manoeuvre	NN	p2=NNS	8	pobj	_
10	with	with	IN	_	9	prep	_
11	Pfizer	pfizer	NNP	_	13	nsubj	13:A0=PAG
12	having	have	VBG	_	13	aux	_
13	ruled	rule	VBN	pb=rule.02	10	pcomp	_
14	out	out	RP	_	13	prt	13:C-V
15	a	a	DT	_	17	det	_
16	hostile	hostile	JJ	_	17	amod	_
17	bid	bid	NN	_	13	dobj	13:A1=PPT
18	.	.	.	_	4	punct	_

1	We	we	PRP	_	4	nsubj	4:A0=PAG
2	will	will	MD	_	4	aux	4:AM-MOD
3	be	be	VB	_	4	aux	_
4	expressing	express	VBG	pb=express.01	0	root	_
5	our	our	PRP$	_	6	poss	_
6	dissatisfaction	dissatisfaction	NN	_	4	dobj	4:A1=PPT
7	to	to	IN	_	6	prep	_
8	the	the	DT	_	10	det	_
9	AstraZeneca	astrazeneca	NNP	_	10	nn	_
10	board	board	NN	_	7	pobj	_
11	over	over	IN	_	6	prep	_
12	the	the	DT	_	13	det	_
13	way	way	NN	_	11	pobj	19:AM-MNR
14	the	the	DT	_	16	det	_
15	bid	bid	NN	p2=VBN	16	nn	_
16	process	process	NN	_	19	nsubjpass	19:A1=PPT
17	has	have	VBZ	_	19	aux	_
18	been	be	VBN	_	19	auxpass	_
19	handled	handle	VBN	pb=handle.01	13	rcmod	_
20	up	up	IN	p2=RP	19	prep	_
21	to	to	IN	_	20	prep	_
22	now	now	RB	_	21	pcomp	_
23	.	.	.	_	4	punct	_
24	"	"	''	_	4	punct	_

1	This	this	DT	_	2	det	_
2	discussion	discussion	NN	_	5	nsubjpass	5:A1=PPT
3	is	be	VBZ	_	5	auxpass	_
4	now	now	RB	_	5	advmod	5:AM-TMP
5	closed	close	VBN	p2=JJ|pb=close.01	0	root	_
6	.	.	.	_	5	punct	_

1	We	we	PRP	_	2	nsubj	2:A0=PAG
2	welcome	welcome	VBP	pb=welcome.01	0	root	_
3	comments	comment	NNS	_	2	dobj	2:A1=PPT
4	on	on	IN	_	3	prep	_
5	our	our	PRP$	_	6	poss	_
6	articles	article	NNS	_	4	pobj	_
7	for	for	IN	_	6	prep	_
8	a	a	DT	_	10	det	_
9	limited	limited	JJ	_	10	amod	_
10	period	period	NN	_	7	pobj	_
11	after	after	IN	_	10	prep	_
12	their	their	PRP$	_	13	poss	_
13	publication	publication	NN	_	11	pobj	_
14	.	.	.	_	2	punct	_

